1
|
Ahmed AS, Gassas RS, Ahmed ME, Osman G, Alsaeed AS, Absi AN, Alamoudi SM, Alahmadi MD, Khalil MM, ElDadah SK, Hemaidi IY, Rajkhan WA. The Role of Pre-bone Marrow Transplantation Pulmonary Function Test in Predicting Post-transplant Noninfectious Pulmonary Complications. Saudi J Med Med Sci 2023; 11:339-344. [PMID: 37970453 PMCID: PMC10634462 DOI: 10.4103/sjmms.sjmms_65_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 06/08/2023] [Accepted: 08/09/2023] [Indexed: 11/17/2023]
Abstract
Background Pulmonary function test (PFT) is used as a tool for pre-transplant risk assessment and as a predictor of post-transplant outcomes. As there are currently few studies that discuss the role of PFT in bone marrow transplantation (BMT) patients in Saudi settings, and as the number of transplant patients with benign and malignant conditions continues to increase, this study was conducted with the aim of assessing the local practice. Methods This retrospective cohort study included all adult patients who underwent BMT at Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah, between 2014 and 2020. The association between established patient-related risk factors and the incidence of pulmonary complications among autologous and allogeneic groups was assessed. Results A total of 186 patients were included (autologous = 143; allogenic = 43), of which 115 (61.8%) were male. At the pre-BMT phase, about 30% of the patients had comorbidities and 51% had received two rounds of salvage chemotherapy, while 16.1% had received radiation therapy. In the autologous group, the only PFT parameter that was a significant predictor of post-BMT pulmonary complications was forced vital capacity <80% (P = 0.012), while in the allogenic group, no parameter was significantly associated with pulmonary complications. The patient-related factors that were associated with respiratory distress in the autologous group were lung involvement (P = 0.03) and pre-transplant radiation (P = 0.044). Conclusion The findings of this study indicated that forced vital capacity <80% was a significant factor in predicting non-infectious complications in the autologous group. Furthermore, lung involvement and pre-transplant radiation were the patient-related factors associated with pulmonary complications.
Collapse
Affiliation(s)
- Amani S. Ahmed
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
| | - Roaa S. Gassas
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
| | - Mohamed E. Ahmed
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
- Department of Basic Sciences, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Ghaya Osman
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
| | - Ahmed S. Alsaeed
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Ahmed N. Absi
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Sameer M. Alamoudi
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Majed D. Alahmadi
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Manar M. Khalil
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
| | - Saleem K. ElDadah
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Ihab Y. Hemaidi
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| | - Walaa A. Rajkhan
- Department of Adult Hematology/Bone Marrow Transplant Section, King Abdulaziz Medical City, Ministry of National Guard–Health Affairs, Jeddah, Saudi Arabia
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
| |
Collapse
|
2
|
Gassas RS, Absi AN, Alghamdi AA, Alsaeed AS, Alamoudi SM, Hemaidi IY, Alahmadi MD, Rajkhan WA, Khalil MM, Dadah SK, Higazi AS, Ahmed AS. Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience. Saudi Med J 2021; 42:847-852. [PMID: 34344808 PMCID: PMC9195543 DOI: 10.15537/smj.2021.42.8.20210236] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Accepted: 06/27/2021] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES To assess local epidemiology and risk factors for bacterial, fungal, and viral infections among the autologous bone marrow transplant population. METHODS This study is a retrospective correlational cohort design comprising 150 adult patients who underwent autologous transplants at Princess Noorah Oncology Center, Jeddah, Saudi Arabia between 2014 and 2020. RESULTS The study findings indicate that bacterial infection prevalence differed significantly across the different disease status pre-salvage as patients with the relapsed disease were more likely to have bacterial infections. The median of engraftment days differed significantly between those who had a bacterial infection and those who did not. Interestingly, previous pneumonia infection had a positive relationship with the number of hospital stays. CONCLUSIONS Bacterial infections are the dominant type of infection among the autologous patient population. The research reflects authentic practice and reports unique characteristics of autologous transplant patients in terms of the prevalence and types of infection these patients experience.
Collapse
Affiliation(s)
- Roaa S. Gassas
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
- Address correspondence and reprint request to: Ms. Roaa S. Gassas, Department of Adult Hematology Blood and Marrow Transplant, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Kingdom of Saudi Arabia. E-mail: ORCID ID: https://orcid.org/0000-0001-5222-213X
| | - Ahmed N. Absi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Abdulrahman A. Alghamdi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Ahmed S. Alsaeed
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Sameer M. Alamoudi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Ihab Y. Hemaidi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Majed D. Alahmadi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Walaa A. Rajkhan
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Mannar M. Khalil
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Saleem K. Dadah
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Ahmed S. Higazi
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| | - Amani S. Ahmed
- From the Department of Adult Hematology Blood and Marrow Transplant (Gassas), King Abdulaziz Medical City, National Guard Health Affairs; and from the Adult Hematology Blood and Marrow Transplant Unit (Absi, Alghamdi, Alsaeed, Alamoudi, Hemaidi, Alahmadi, Rajkhan, Khalil, Dadah, Higazi, Ahmed), Princess Noorah Oncology Center, Jeddah, Kingdom of Saudi Arabia.
| |
Collapse
|